Global orthopedic sales totaled $62 billion in 2024, an increase of 5% compared to 2023. Read our regularly updated analysis of the orthopedic market, including sales forecasts for all segments, company revenue and insight into key trends.
The Numbers
Dr. Natalie Mesnier says minimally invasive bunion surgery has transformed her practice and is gaining greater adoption among surgeons.
The company grew in the low double digits in 1Q25 on the strength of new product introductions and robust international sales.
The company grew in the low double digits in 1Q25 on the strength of new product introductions and robust international sales.
May 16, 2025
,
Through the first four months of the year, orthopedic funding is off to its slowest start in the last decade.
May 14, 2025
,
The company grew in the mid-teens and could see even greater demand with MACI Arthro’s use for trochlea defects.
May 14, 2025
,
Insight’s EmbedMed platform digitizes the surgical planning process and allows for rapid design and manufacture of patient-specific guides for orthopedic surgery.
May 14, 2025
,
The company’s orthopedic sales declined about 10% in the first quarter of 2025, but its commercial channel showed ample promise.
May 13, 2025
,
The company grew in the low single digits for the first quarter of 2025 and expects accelerating growth through the year.
May 13, 2025
,
Stay up to date on the orthopedic market’s 1Q performance in 2025 as we update this post with company sales data and industry developments.
May 12, 2025
,
The company faced market softness, supply issues and international order timing lumpiness as it declined in the low single digits.
May 12, 2025
,
The company’s orthopedic sales grew 6% in the first quarter of 2025 on the strength of DUROLANE and Exogen.
May 9, 2025
,
The company grew nearly 25% in the first quarter of 2025 as its physician user base reached record levels.
May 9, 2025
,
The company grew in the low single digits for 1Q25 due to one less selling day and distributor team transitions.
May 8, 2025
,
The company grew in the low single digits in the first quarter of 2025 and it retools its U.S. sales channel.
May 7, 2025
,
The company grew more than 20% in the first quarter of 2025 as it seeks to cement itself as the largest pure-play spine company.
May 6, 2025
,
The company maintained its exceptional pace of orthopedic growth during the first quarter of 2025 driven by execution and robotic procedures.
May 5, 2025
,
The company grew in the low single digits in the first quarter of 2025 as it incrementally improves its performance.
